David Owens Nexalin Technology, Inc. (NXL) insider trading activity
David Owens is Chief Medical Officer of Nexalin Technology, Inc.. Currently has a direct ownership of 191,252 shares of NXL, which is worth approximately $179,776. The most recent transaction as insider was on Sep 29, 2025, when has been sold 36,459 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
191K
22.76%
3M change
29.41%
12M change
Total Value Held
$179,776
David Owens Transaction History
DO
David Owens
Chief Medical Officer
Atlanta, GA